Objectives Circulating antibodies are important markers of previous infection and immunity.
Questions remain with respect to the durability and functionality of SARS‐CoV‐2 antibodies. …

We conducted a multicentre cross sectional observational study of laboratory, public health
and hospitalisation data for PCR-confirmed COVID-19 cases within the New Zealand …

Background: There is increasing awareness of the need to implement quality assurance
programs in developing countries. Healthcare staff are the primary drivers of improving the …

We describe three cases with viral strains that demonstrate impaired N2-gene detection on
the Cepheid Xpert Xpress SARS-CoV-2 assay, with two previously undescribed single …

Background: Serological assays that detect antibodies to SARS-CoV-2 are critical for
determining past infection and investigating immune responses in the COVID-19 pandemic. We …

Background Antimicrobial resistance threatens human health worldwide. Antimicrobial
misuse is a major driver of resistance. Promoting appropriate antimicrobial use requires an …

[...] this method is subject to the quality of collection and changes in viral dynamics over time.
1 Serological assays can diagnose SARSCoV-2 infections where exposure was several …

Utilising diverse molecular platforms has formed a solid foundation in New Zealand’s COVID-19
response. We evaluated multiple extraction and PCR assays for the detection of SARS-…

Objective The purpose of this evaluation is to explore the impact of the new hospital community
engagement programme (comprised of a Young Persons Advisory Group and a Science …

Objective To explore Cambodian community members’ understanding of and attitudes
towards healthcare research. Design This qualitative study generated data from semi-structured …